Association between the HSPA1B ±1267A/G Polymorphism and Cancer Risk: a Meta-analysis of 14 Case-Control Studies

  • Kuang, Dan (Chengdu Municipal Center for Disease Control and Prevention) ;
  • Chen, Wei (Laiwu Municipal Center for Disease Control and Prevention) ;
  • Song, Yue-Zhang (Laiwu Municipal Center for Disease Control and Prevention) ;
  • Yu, Yan-Yan (Chengdu Municipal Center for Disease Control and Prevention) ;
  • Zhang, Dong-Ying (School of Public Health, Guangzhou Medical University) ;
  • Wu, Lang (Center for Clinical and Translational Science, Mayo Clinic) ;
  • Tang, Jie (School of Public Health, Guangzhou Medical University)
  • Published : 2014.08.30


Background: Previous epidemiological studies have suggested a potential role of the $HSPA1B{\pm}1267A/G$ polymorphism in risk of developing cancer. However, the results were inconsistent. Therefore, we performed this meta-analysis to summarize the possible association with cancer risk. Materials and Methods: We retrieved relevant articles from PubMed, EMBASE, ISI Web of Science, Chinese Biomedical Literature and Chinese National Knowledge Infrastructure. Studies were selected using specific criteria. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to assess those associations. All analyses were performed using STATA software. Results: Fourteen case-control studies, including 1, 834 cancer cases and 2, 028 controls were included in this meta-analysis. Overall, the results indicated that the G allele of HSPA1B gene ${\pm}1267A/G$ was significantly associated with an increased cancer risk in all genetic models (G vs A: OR=1.51, 95%CI 1.17-1.95, p=0.001; GG vs AA: OR=2.93, 95%CI 1.50-5.74, p=0.002; AG vs AA: OR=1.48, 95%CI 1.10-1.98, p=0.009; GG/AG vs AA: OR=1.69, 95%CI 1.22-2.33, p=0.001; GG vs AG/AA: OR=2.31, 95%CI 1.24-4.32, p=0.009). In the subgroup analysis stratified by ethnicity, a significant association was identified in Caucasians (G vs A: OR=1.35, 95%CI 1.08-1.69, p=0.008; GG/AG vs AA: OR=1.36, 95%CI 1.09-1.70, p=0.007), but not in Asians. In the stratified analysis by cancer types, individuals with the G allele showed an increased risk of hepatocellular carcinoma compared with carriers of the A allele (OR=2.40, 95%CI 1.47-3.91, p<0.001). Inversely, individuals with the GG genotype showed a decreased risk of gastric cancer compared with carriers of the AG/GG genotypes (GG vs AG/AA: OR=0.39, 95%CI 0.20-0.70, p=0.007). Conclusions: This meta-analysis suggests associations between the HSPA1B ${\pm}1267A/G$ polymorphism and risk of cancer. However, this association might be Caucasian-specific and the G allele of this polymorphism probably increases risk of hepatocellular carcinoma while decreasing risk of gastric cancer. Further well-designed studies based on larger sample sizes are needed to validate these findings.


Heat-shock proteins (HSPs);cancer risk;polymorphism;meta-analysis


Supported by : National Natural Science Foundation of China


  1. Anand K, Asthana P, Kumar A, et al (2011). Quercetin mediated reduction of angiogenic markers and chaperones in DLAinduced solid tumours. Asian Pac J Cancer Prev, 12, 2829-35.
  2. Asea A, Kraeft SK, Kurt-Jones EA, et al (2000). HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med, 6, 435-42.
  3. Becker J, Craig EA (1994). Heat-shock proteins as molecular chaperones. Eur J Biochem, 219, 11-23.
  4. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101.
  5. Broderick P, Wang Y, Vijayakrishnan J, et al (2009). Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. Cancer Res, 69, 6633-41.
  6. Cai YY, Lin WP, Li AP, et al (2013). Combined effects of curcumin and triptolide on an ovarian cancer cell line. Asian Pac J Cancer Prev, 14, 4267-71.
  7. Calderwood SK, Khaleque MA, Sawyer DB, et al (2006). Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci, 31, 164-72.
  8. Chouchane L, Ahmed SB, Baccouche S, et al (1997). Polymorphism in the tumor necrosis factor-alpha promotor region and in the heat shock protein 70 genes associated with malignant tumors. Cancer, 80, 1489-96.<1489::AID-CNCR17>3.0.CO;2-1
  9. Ciocca DR, Calderwood SK (2005). Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones, 10, 86-103.
  10. Ciocca DR, Clark GM, Tandon AK, et al (1993). Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications. J Natl Cancer Inst, 85, 570-4.
  11. Constantinescu E, Volanschi D, Pintilie C (1975). Comparative study of proteins and lactic dehydrogenase isoenzymes in the blood and cerebrospinal fluid of nontreated and of phenobarbital and diphenylhydantoin treated epileptic patients. Neurol Psychiatr, 13, 195-203.
  12. DeNagel DC, Pierce SK (1992). A case for chaperones in antigen processing. Immunol Today, 13, 86-9.
  13. DerSimonian R, LairdN (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 77-188.
  14. Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
  15. Ferrer-Ferrer M, Malespin-Bendana W, Ramirez V, et al (2013). Polymorphisms in genes coding for HSP-70 are associated with gastric cancer and duodenal ulcer in a population at high risk of gastric cancer in Costa Rica. Arch Med Res, 44, 467-74.
  16. Garrido C, Brunet M, Didelot C, et al (2006). Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle, 5, 2592-601.
  17. Georgopoulos C, Welch WJ (1993). Role of the major heat shock proteins as molecular chaperones. Annu Rev Cell Biol, 9, 601-34.
  18. Hartl FU, Hayer-Hartl M (2002). Molecular chaperones in the cytosol: from nascent chain to folded protein. Science, 295, 1852-8.
  19. Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58.
  20. Higgins JP, Thompson SG (2004). Controlling the risk of spurious findings from meta-regression. Stat Med, 23, 1663-82.
  21. Hung RJ, McKay JD, Gaborieau V, et al (2008). A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature, 452, 633-7.
  22. Jalbout M, Bouaouina N, Gargouri J, et al (2003). Polymorphism of the stress protein HSP70-2 gene is associated with the susceptibility to the nasopharyngeal carcinoma. Cancer Lett, 193, 75-81.
  23. Jeng JE, Tsai JF, Chuang LY, et al (2008). Heat shock protein A1B 1267 polymorphism is highly associated with risk and prognosis of hepatocellular carcinoma: a case-control study. Medicine 87, 87-98.
  24. Khalil AA, Kabapy NF, Deraz SF, et al (2011). Heat shock proteins in oncology: diagnostic biomarkers or therapeutic targets? Biochim Biophys Acta, 1816, 89-104.
  25. Latvala A, Dick DM, Tuulio-Henriksson A, et al (2011). Genetic correlation and gene-environment interaction between alcohol problems and educational level in young adulthood. J Stud Alcohol Drugs, 72, 210-20.
  26. Li WQ, Wang CD, Lin JA, et al (2010). Relationship of heat shock protein 70-2 gene polymorphism with hepatocellular carcinoma. Zhonghua Gan Zang Bing Za Zhi, 18, 538-9.
  27. Medhi S, Sarma MP, Asim M, et al (2013). Genetic variants of heat shock protein A1L2437 and A1B1267 as possible risk factors for hepatocellular carcinoma in India. J Viral Hepat, 20, e141-7.
  28. Mestiri S, Bouaouina N, Ahmed SB, et al (2001). Genetic variation in the tumor necrosis factor-alpha promoter region and in the stress protein hsp70-2: susceptibility and prognostic implications in breast carcinoma. Cancer, 91, 672-8.<672::AID-CNCR1050>3.0.CO;2-J
  29. Milner CM, Campbell RD (1992). Polymorphic analysis of the three MHC-linked HSP70 genes. Immunogenetics, 36, 357-62.
  30. Peters JL, Sutton AJ, Jones DR, et al (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA, 295, 676-80.
  31. Radons J, Multhoff G (2005). Immunostimulatory functions of membrane-bound and exported heat shock protein 70. Exerc Immunol Rev, 11, 17-33.
  32. Rehman SU, Sameer AS, Zahoor L, et al (2009). Polymorphic analysis of MHClinked Heat Shock Protein 70 genes: Their susceptibility and prognostic implication in Kangri cancer cases of Kashmiri population. Indian J Hum Genet, 15, 65-71.
  33. Schaid DJ, Jacobsen SJ (1999). Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions. Am J Epidemiol, 149, 706-11.
  34. Schroeder S, Bischoff J, Lehmann LE, et al (1999). Endotoxin inhibits heat shock protein 70 (HSP70) expression in peripheral blood mononuclear cells of patients with severe sepsis. Intensive Care Med, 25, 52-7.
  35. Shibata T, Arisawa T, Tahara T, et al (2009). Protective role of genetic polymorphism of heat shock protein 70-2 for gastric cancer risk. Dig Dis Sci, 54, 70-4.
  36. Srivastava P, Shafiq N, Bhasin DK, et al (2012). Differential expression of heat shock protein (HSP) 70-2 gene polymorphism in benign and malignant pancreatic disorders and its relationship with disease severity and complications. JOP, 13, 414-9.
  37. Toth EK, Kocsis J, Madaras B, et al (2007). The 8.1 ancestral MHC haplotype is strongly associated with colorectal cancer risk. Int J Cancer, 121, 1744-8.
  38. Wang Y, Broderick P, Webb E, et al (2008). Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet, 40, 1407-9.
  39. Wang Y, Zhou F, Wu Y, et al (2010). The relationship between three heat shock protein 70 gene polymorphisms and susceptibility to lung cancer. Clin Chem Lab Med, 48, 1657-63.
  40. Wu YR, Wang CK, Chen CM, et al (2004). Analysis of heatshock protein 70 gene polymorphisms and the risk of Parkinson's disease. Hum Genet, 114, 236-41.
  41. Wu YZ, Yang H, Zhang L, et al (2012). Application of crossover analysis-logistic regression in the assessment of geneenvironmental interactions for colorectal cancer. Asian Pac J Cancer Prev, 13, 2031-7.
  42. Zagouri F, Sergentanis TN, Gazouli M, et al (2012). HSP90, HSPA8, HIF-1 alpha and HSP70-2 polymorphisms in breast cancer: a case-control study. Mol Biol Rep, 39, 10873-9.
  43. Zintzaras E, Ioannidis JP (2005). Heterogeneity testing in metaanalysis of genome searches. Genet Epidemiol, 28, 123-37.

Cited by

  1. Profiles of Epstein-Barr Virus Associated Gastric Carcinomas in Brunei Darussalam vol.15, pp.23, 2015,
  2. Fish consumption and risk of myeloma: a meta-analysis of epidemiological studies vol.26, pp.9, 2015,
  3. Pharmacologic Therapy of Diabetes and Overall Cancer Risk and Mortality: A Meta-Analysis of 265 Studies vol.5, pp.1, 2015,
  4. Polymorphisms in Heat Shock Proteins A1B and A1L (HOM) as Risk Factors for Oesophageal Carcinoma in Northeast India vol.16, pp.18, 2016,
  5. Low circulating ghrelin levels in women with polycystic ovary syndrome: a systematic review and meta-analysis vol.63, pp.1, 2016,
  6. Circulating Nesfatin-1 Levels and Type 2 Diabetes: A Systematic Review and Meta-Analysis vol.2017, pp.2314-6753, 2017,
  7. Long-term clinical outcomes of successful revascularization with drug-eluting stents for chronic total occlusions: A systematic review and meta-analysis vol.89, pp.S1, 2017,
  8. Prognostic Significance of Statin Use in Colorectal Cancer vol.94, pp.25, 2015,